L
Liping Liu
Researcher at Capital Medical University
Publications - 418
Citations - 11181
Liping Liu is an academic researcher from Capital Medical University. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 40, co-authored 317 publications receiving 7618 citations. Previous affiliations of Liping Liu include Society of American Military Engineers.
Papers
More filters
Journal ArticleDOI
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang,Yilong Wang,Xingquan Zhao,Liping Liu,David Wang,Chunxue Wang,Chen Wang,Hao Li,Xia Meng,Liying Cui,Jianping Jia,Qiang Dong,Anding Xu,Jinsheng Zeng,Yansheng Li,Zhimin Wang,Haiqin Xia,S. Claiborne Johnston +17 more
TL;DR: Among patients with TIA or minor stroke who can be treated within 24 hours after the onset of symptoms, the combination of clopidogrel and aspirin is superior to aspirin alone for reducing the risk of stroke in the first 90 days and does not increase the riskof hemorrhage.
Journal ArticleDOI
Stroke and Stroke Care in China: Huge Burden, Significant Workload, and a National Priority
TL;DR: The recently completed Chinese National Stroke Registry has provided new information on the status of stroke epidemiology, diagnosis, management, and prevention strategies in China, and the challenges in risk factor modification and secondary stroke prevention.
Journal ArticleDOI
Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in China: The Chinese Intracranial Atherosclerosis (CICAS) Study
Yongjun Wang,Xingquan Zhao,Liping Liu,Yannie Soo,Yuehua Pu,Yuesong Pan,Yilong Wang,Xinying Zou,Thomas W. Leung,Yefeng Cai,Qingke Bai,Yiping Wu,Chunxue Wang,Xiaoping Pan,Benyan Luo,Ka Sing Lawrence Wong,Xiaojun Zhang,Xiaojiang Sun,Lan Yu,Minxia Guo,Qilin Ma,Bo Xiao,Le Zhang,Zhong Zhang,Anding Xu,Jun-Tao Li,Jie Lin,Chengming Xing,Yuming Xu,Rongyuan Zheng,Zhao Han,Xiaodong Yuan,Wanlin Cui,Yuan Zou,Heli Yan +34 more
TL;DR: Recurrent stroke rate in this study was lower compared with those of previous clinical trials but remains unacceptably high in a subgroup of patients with severe stenosis.
Journal ArticleDOI
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations.
Yongjun Wang,Zixiao Li,Hongqiu Gu,Yi Zhai,Yong Jiang,Xingquan Zhao,Yilong Wang,Xin Yang,Chunjuan Wang,Xia Meng,Hao Li,Liping Liu,Jing Jing,Jing Wu,Anding Xu,Qiang Dong,David Z. Wang,Ji-Zong Zhao +17 more
TL;DR: The most prevalent risk factors among stroke survivors were hypertension (63.0%-84.2%), and smoking (31.7%-47.6%), while the least prevalent was AF (2.7-7.4%). The prevalences for major risk factors for stroke are high and most have increased over time as discussed by the authors.
Journal ArticleDOI
Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack
Yilong Wang,Xingquan Zhao,Jinxi Lin,Hao Li,S. Claiborne Johnston,Yi Lin,Yuesong Pan,Liping Liu,David Wang,Chunxue Wang,Xia Meng,Jianfeng Xu,Jianfeng Xu,Yongjun Wang +13 more
TL;DR: Findings support a role of CYP2C19 genotype in the efficacy of this treatment, and the use of clopidogrel plus aspirin compared with aspirin alone reduced the risk of a new stroke only in the subgroup of patients who were not carriers of the CYP1C19 loss-of-function alleles.